Hi-Tech Pharmacal and its subsidiary ECR Pharmaceuticals announced the launch of Hylase Wound Gel for the management and treatment of leg ulcers, pressure ulcers, diabetic ulcers, and exuding wounds prone to bleeding. Hylase Wound Gel contains sodium hyaluronate, a salt of hyaluronic acid that has demonstrated efficacy in maintaining tissue hydration and supporting the healing process, in an emollient based gel.

Hylase Wound Gel is supplied in a 75g tube size and will be available by prescription only.

For more information, call (804) 527-1950 or visit www.ecrpharma.com.